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Bacillus amyloliquefaciens MEP218 is an autochthonous bacterial isolate with
antibacterial and antifungal activities against a wide range of phytopathogenic
microorganisms. Cyclic lipopeptides (CLP), particularly fengycins, produced by this
bacterium; are the main antimicrobial compounds responsible for the growth inhibition
of phytopathogens. In this work, the CLP fraction containing fengycins with antibacterial
activity was characterized by LC-ESI-MS/MS. In addition, the antibacterial activity
of these fengycins was evaluated on the pathogens Xanthomonas axonopodis
pv. vesicatoria (Xav), a plant pathogen causing the bacterial spot disease, and
Pseudomonas aeruginosa PA01, an opportunistic human pathogen. In vitro inhibition
assays showed bactericidal effects on Xav and PA01. Atomic force microscopy
images revealed dramatic alterations in the bacterial surface topography in response to
fengycins exposure. Cell damage was evidenced by a decrease in bacterial cell heights
and the loss of intracellular content measured by potassium efflux assays. Furthermore,
the viability of MRC-5 human normal lung fibroblasts was not affected by the treatment
with fengycins. This study shows in vivo evidence on the less-known properties of
fengycins as antibacterial molecules and leaves open the possibility of using this CLP as
a novel antibiotic.
Keywords: cyclic lipopeptides, atomic force microscopy, Bacillus amyloliquefaciens, cell surface, fengycin
treatments
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INTRODUCTION
Among the notable characteristics of the members of the Bacillus
subtilis group, which is originally composed by the species
B. subtilis, Bacillus licheniformis, Bacillus pumilus, and Bacillus
amyloliquefaciens and subspecies derived from them (Fan et al.,
2017; Caulier et al., 2019), are the production of several bioactive
molecules to control crop diseases (Fira et al., 2018; Rabbee et al.,
2019) and the ability to form endospores, the resistance structures
to withstand adverse environmental conditions. B. subtilis group
strains act antagonistic to a broad range of pathogens by
producing a wide diversity of secondary metabolites (Caulier
et al., 2019). It is estimated that 4 to 5% of the genome of
the strains belonging to the B. subtilis group is dedicated to
the production of antimicrobial molecules, which are typically
antimicrobial peptides with diverse chemical structures and
moieties. Bioactive volatile metabolites and polyketides are
also produced by the B. subtilis group (Stein, 2005; Caulier
et al., 2019). These characteristics give Bacillus subtilis group
species great competitive advantages and make these attractive
microorganisms for the industrial production of biopesticides
and antibiotics (Borriss, 2011; Wu et al., 2015; Fira et al., 2018;
Rabbee et al., 2019).
Among the broad spectrum of bioactive secondary metabolites
produced by the Bacillus subtilis group, the antifungal activity of
cyclic lipopeptides (CLP) including the three families, surfactins,
iturins and fengycins, have been widely documented (Ongena
and Jacques, 2008; Raaijmakers et al., 2010; Cochrane and
Vederas, 2016). In addition to antifungal properties, antiviral,
anticancer, and antibacterial have also been reported (Ongena
and Jacques, 2008; Wu et al., 2017; Zhao et al., 2017, 2018). The
CLP exhibit others plant growth-promoting features desirable for
agriculture, for example as a signal inducer of systemic resistance
in plants (Ongena et al., 2005; Ongena and Jacques, 2008;
Cawoy et al., 2014; Chowdhury et al., 2015). The biosynthesis
of CLP is carried out by multifunctional megasynthetases
called non-ribosomal peptide synthetases (NRPSs). The peptide
moiety synthesized by these megaenzymes can be short, linear,
cyclic, or branched-cyclic. Amino acids modifications such as
epimerization, methylation or hydroxylation are frequent, giving
place to a vast structural diversity of peptides produced by each
Bacillus strain (Gao et al., 2018). Therefore, it is interesting to
explore the antimicrobial activities of CLP produced by novel
native Bacillus strains.
The antibacterial activity of CLP against several pathogens
such as Corynebacterium variabilis, Acinetobacter, Staphylococcus
aureus, B. subtilis, Salmonella typhimurium, Pseudomonas
aeruginosa, Enterobacter cloacae and Xanthomonas campestris,
among others, has been attributed to iturins and surfactins
(Zhao et al., 2018). Fengycins are one of the major types of
CLP produced by Bacillus, and activity reports have mainly
been restricted to antifungal effects (Ongena and Jacques, 2008;
Han et al., 2015; Wu et al., 2015; Cochrane and Vederas,
2016; Lu et al., 2016; Fira et al., 2018). For example, fengycin
BS155 induces alterations at the level of the cell membrane and
organelles, processes that lead to cell death in Magnaporthe grisea
(Zhang and Sun, 2018).
Nevertheless, some authors have also reported a significant
but indirect relationship between the antibacterial activity and
the production of fengycins. Such antibacterial activity was
only evidenced after the modification of fengycin molecules by
self-assembly (Roy et al., 2013). Previously, we demonstrated
that B. amyloliquefaciens MEP218 (MEP218), a plant growth-
promoting rhizobacterium (PGPR), produces fengycins A and B
when grown in an optimized lipopeptides production medium.
These fengycins exhibited an increased antibacterial activity
against Xanthomonas axonopodis pv. vesicatoria (Xav), the
phytopathogenic bacterium causing the widespread and harmful
bacterial spot disease on tomato plants (Solanum lycopersicum)
in comparison with those obtained in the unmodified culture
medium (Medeot et al., 2017).
The effect of fengycins on the bacterial cell is poorly
documented. Most studies show that fengycins are inserted into
model biomembranes, due to its amphiphilic characteristics,
establishing fengycin-rich domains which constitute
permeabilization sites that result in a leaky target membrane
(Deleu et al., 2008; González-Jaramillo et al., 2017).
The aim of this work was to study the effect of fengycins
produced by MEP218 on two pathogenic bacteria by using
atomic force microscope (AFM) and to evaluate the cytotoxic
effect of this CLP on human normal lung fibroblasts. The
pathogenic bacteria selected for the experiments were Xav, as
phytopathogen model, and P. aeruginosa PA01, an opportunistic
pathogen of growing clinical relevance. Xav is a phytopathogen
that has acquired resistance to the most commonly used control
methods. The emergence of copper-tolerant Xanthomonas strains
constitutes a serious problem for farmers (Potnis et al., 2015;
Strayer-Scherer et al., 2018). P. aeruginosa is an opportunistic
pathogen that, due to its metabolic versatility, is able to colonize
several niches, being a serious problem in hospitalized patients
and a leading cause of morbidity and mortality in patients
with cystic fibrosis or immunocompromised. The control of
infections caused by P. aeruginosa is increasingly difficult due
to its notorious ability to resist antibiotics either through
intrinsic or acquired resistance mechanisms. The finding and
development of alternative therapeutic strategies for controlling
infections produced by P. aeruginosa are increasingly demanded
(Pang et al., 2019).
The AFM technique allowed us to visualize, at the single
cellular level, that fengycins induced changes on the cell
topography which probably are associated with cell death. The
confirmation of the damage to the cellular envelope caused by
fengycins was obtained from the data of potassium efflux assays.
Furthermore, the promising antibiotic properties of fengycins
are supported by the non-cytotoxic effects since the viability of
human normal lung fibroblasts (cell line MRC-5) was not affected
by fengycins treatment.
MATERIALS AND METHODS
Microorganisms and Growth Conditions
The MEP218 strain is an autochthonous bacterium isolated from
a saline soil of the south of the Córdoba province, Argentina.
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This strain possesses biocontrol properties (Príncipe et al., 2007;
Alvarez et al., 2012). The MEP218 was grown in Lysogeny
broth (LB) or in Modified Medium Optimal for Lipopeptide
Production (MMOLP) (Medeot et al., 2017) for 48 h at 30◦C
and 150 rev min−1. Xav, the phytopathogenic bacterium causing
the bacterial spot disease on pepper (Capsicum spp.) and tomato
(Lycopersicon spp.) plants (Thieme et al., 2005), was routinely
grown for 24 h at 30◦C on nutrient agar (NA) plates or
nutrient broth. Pseudomonas aeruginosa PA01 (ATCC 15692),
a well-known and metabolically versatile opportunistic human
pathogen, was routinely grown for 24 h at 37◦C on LB agar plates.
All strains were stored at−80◦C in saline buffer (0.7% Na2HPO4,
0.3% KH2PO4, and 0.5% NaCl) plus 20% glycerol.
Isolation of Cyclic Lipopeptides and
Fengycin Purification
Cyclic lipopeptides from MEP218 were precipitated from the
cell free culture supernatant following acidification with HCl
(12 N) until pH = 2,0 (Vater et al., 2002; Kim et al., 2004;
Medeot et al., 2017). Precipitated CLP were suspended in
100% methanol, filtered through a 0.22 µm nylon membrane,
and injected onto a high-performance liquid chromatography
(HPLC) (Infinity LC Grad, Agilent) column (Analytical Zorbax
C18, 4.6 mm × 150 mm, Agilent). The temperature was
maintained at 37◦C. Separation was achieved by using a
mixture of solvents consisting of acetonitrile (solvent A) and
water acidified with 0.1% formic acid (solvent B) with a flow
rate of 1 mL min−1. For each run, 100 µl of sample was
injected into the HPLC column and eluted using the conditions
described in Medeot et al. (2017).
The peaks with a retention time of 27.4 min, corresponding
to fengycins (Medeot et al., 2017), from several HPLC runnings
were collected, lyophilized and the powder was weighed and
suspended in 100% methanol at final concentrations of 1 and
10 mg mL−1. These solutions were used as stocks of fengycins.
Mass Spectrometry
Fengycins stock (1 mg mL−1) was submitted to the Center
for Chemical and Biological Studies Maldi Tof Spectrometry
(CEQUIBIEM, University of Buenos Aires, Argentina) for
spectrometric analysis. Fengycins were purified with ZipTips
C18 and analyzed by nanoHPLC (Thermo Scientific, EASY-
nLC 1000) equipped with a reverse-phase C18 column (Easy-
Spray ColumnPepMap RSLC, P/N ES803, 2 µm particle size,
75 µm× 500 mm, Thermo Scientific) at 35◦C. A two component
solvent system was used: solvent A is water (HPLC grade)
acidified with 0.1% formic acid and solvent B is acetonitrile with
0.1% formic acid. For each run, 4 µl of sample was injected into
a nanoHPLC system and eluted using the following gradient (%
A:B v/v): injection start (95:5), 5 min isocratic (95:5), then an
increasing gradient of solvent B to 50% through 80 min, then an
increasing gradient of solvent B to 80% through 5 min and finally
10 min isocratic (20:80). The elution program used a flow rate of
200 nL min−1.
For ESI-MS/MS experiments the spectra were recorded in
positive ion mode using a mass spectrometer (Thermo Scientific,
Q-Exactive) with a High Collision Dissociation (HCD) cell and
an Orbitrap analyzer. The ionization of the samples was done by
electrospray (Thermo Scientific EASY-SPRAY. Voltage: 2,25 kV).
The 10 most abundant ions of each scan were subjected to
MS/MS analysis with a dynamic exclusion range. The analysis
of the data was performed with the Xcalibur 3.1 software
(Thermo Scientific).
Analysis of Antibacterial Activity of
Fengycin
The antibacterial activity of fengycins against Xav and PA01 was
tested on NA and LB agar plates respectively, by using the disk
diffusion method as described by Medeot et al. (2017). Briefly, an
aliquot from a culture of Xav and PA01 (grown until OD600 = 0.3–
0.4, the logarithmic phase of growth) was spread on a plate.
Different concentrations (6.25, 12.5, and 25 µg mL−1 for Xav and
25, 50, 100, and 200 µg mL−1 for PA01) of fengycins (contained
in a final volume of 10 µL) were deposited on sterile paper
disks. The imbibed paper disks were left for 10 min under the
sterile airflow to allow methanol evaporation, and then they were
deposited onto the plate. After incubation for 24 h at 30◦C,
inhibition zones were visualized and the diameter of the zone
formed around each paper disk was recorded. Control consisted
of paper disks imbibed with 10 µL of methanol. The assay was
performed in triplicate.
Determination of Minimal Inhibitory
Concentration
The minimum inhibitory concentration (MIC) of fengycins on
Xav and PA01 was determined by the microtiter plate dilution
assay (Baindara et al., 2013). Xav and PA01 were grown until
OD600 = 0.3–0.4 in nutritive broth or LB, respectively. Aqueous
solutions of 0, 1.5, 3.12, 6.25, 12.5, 25, 50, 100, and 200 µg ml−1 of
fengycins were used. The lowest concentration of fengycins that
inhibited the growth of the bacteria and did not show any increase
in the OD600 after 48 h of incubation was considered as the MIC.
The assay was performed in triplicate.
Cell Viability Determination
Cell Culture
MRC-5 human normal lung fibroblasts were cultured as
previously described (Lamberti et al., 2019). Briefly, they were
grown in complete medium DMEM (Dulbecco’s modified Eagle
medium high glucose 1X, Gibco) supplemented with 10% v/v
fetal bovine serum (FBS) (PAA Laboratories), 1% v/v glutamine
(GlutaMAXTM 100X Gibco), 1% v/v antibiotic (Penicillin 10,000
units mL−1 – streptomycin 10,000 µg mL−1 Gibco) and 1%
v/v of sodium pyruvate 100 mM (Gibco), in 5% CO2 and
95% air at 37◦C in a humidified incubator. Stock cultures were
stored in liquid nitrogen and used for experimentation within
5 to 7 passages.
Cell Treatment
Exponential-phase MRC-5 cells at a density of 5 × 104 cells
mL−1 were plated onto 96-well plates, using 100 µl per well in
complete medium. Following an overnight incubation to allow
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attachment, fengycins (100–200 µg/ml) were added to each well
and incubated for 24 h (37◦C, 5% CO2) in complete medium.
Control cells were treated with vehicle alone (phosphate buffer
saline). The assay was performed in triplicate.
Cell Viability Quantification
Cell viability was evaluated by 1-(4,5-dimethylthiazol-2-yl)-
3,5-diphenylformazan (MTT) assay, which is reduced by
mitochondrial dehydrogenases of viable cells to non-water
soluble violet formazan crystals, as previously described
(Lamberti et al., 2013, 2018). Briefly, MTT solution (5 mg mL−1
in phosphate buffer saline) was added for 3 h (dilution rate:
1/10). Then, DMSO was added to lyse the cells and solubilize the
precipitated formazan product. Optical density of the formazan
salt was read at 540 nm using ELISA reader plate (Thermo
Scientific, Multiskan FC). The assay was performed in triplicate.
Atomic Force Microscopy of Bacterial
Cells Treated With Fengycin
Cells of Xav and PA01 were obtained after centrifugation
(3500 × g for 2 min) of cultures grown until OD600 = 0.5.
Cells were washed three times and suspended in water. Cell
suspensions were treated with fengycins (dissolved in water) at
final concentrations of 12.5, 25, 50, and 75 µg mL−1 for Xav, and
100 and 200 µg mL−1 for PA01. The suspensions were incubated
for 90 min for Xav and 6 h for PA01 at 28◦C and 150 rpm, and
later washed twice with water. The control experiment consisted
of the same treatment but replacing the fengycins by water. The
assay was performed in triplicate.
Afterward, treated bacterial cells were immobilized
electrostatically by depositing 15 µL of the bacterial suspension
over polyethyleneimine coated glass slides (Dufrêne, 2008).
After 30 min of incubation at 28◦C, the slides were washed with
water, dried and mounted for observation. Topographic images
were obtained with an AFM (Agilent, Technologies, SPM model
5500) in air and working in acoustic AC mode (Fernandez et al.,
2017). The experiments were performed using AFM probes
(Micromasch, HQ:XSC11/A1 BS) with a cantilever resonance
frequency and force constant of 155 kHz and 7 N/m respectively.
The bacterial height analysis was performed by measuring 70
individual cells per treatment, using statistical tools and modules
offered in Gwyddion v2.391. Analysis of variance followed by
Tukey test was carried out by using software R2. In all cases,
p ≤ 0.05 was considered as significance level.
Potassium Ion Efflux
Cells of Xav, grown in nutrient broth at 30◦C until OD600 = 0.5,
were collected by centrifugation (10,000 × g for 15 min) and
washed three times with water. After resuspension in water,
at the original volume, each sample was split into two. One
of them was supplemented with fengycins at the MIC value
(25 µg mL−1) and another three times higher to ensure the total
cell lysis (75 µg mL−1) and the other one with water (negative
control). After 90 min of treatment, aliquots (1 mL) of each
1http://gwyddion.net/
2http://www.r-project.org/
cell suspensions were centrifuged at 13,000 × g for 5 min and
the supernatants were filtered by using a 0.2 µm pore size filter
and transferred to new tubes. Positive control consisted of cell
suspensions boiled for 10 min to release intracellular K+ ions
(Cushnie and Lamb, 2005). The concentration of K+ ions was
determined in the supernatants using a single-channel flame
photometer (Digital Flame Analyzer Cole-Parmer). Calibration
curves were obtained with potassium standards in the range of 1–
20 ppm K+ mL−1. The results informed are the average of three
different experiments with three replicates.
RESULTS
LC-ESI-MS/MS Analysis of Fengycins
From B. amyloliquefaciens MEP218
Previously, we reported that changes in the sources and ratios of
C and N in the culture medium can modulate the production
of CLP in MEP218. Specifically, MMOLP medium enhanced
the production of different isoforms of fengycins A and B
(Medeot et al., 2017). To accurately determine the variants
of fengycins produced by the strain MEP218 in MMOLP, the
HPLC-purified fraction eluted at 27.4 min and containing the
fengycins was subjected to liquid chromatography–electrospray
ionization mass/mass spectrometry (LC/ESI-MS/MS) analysis.
The LC profile shows three peaks, at the retention times where
fengycins elute (Figure 1A). Fengycins were identified according
to the typical mass values of these compounds (1400–1500 Da)
(Monaci et al., 2016). Mass spectra of peaks 1, 2, and 3 from LC
(Figure 1A) displayed peaks at m/z 1463.8 (Figure 1B), 1477.8
(Figure 1D), 1477.8, 1491.8, and 1505.8 (Figure 1F), respectively,
and they represent different fengycins homologs. From each
ion, selected as the precursor ion, an additional fragmentation
was performed and the resultant ESI-MS/MS spectrum was
analyzed. Product ions at m/z 966 and 1080 were found in
the MS/MS spectra of precursor ions at m/z 1463.8 and 1477.8
(Figures 1C,G) while product ions at m/z 994 and 1108 were
observed in MS/MS spectra of precursor ions at m/z 1491.8
and 1505.8 (Figures 1H,I). Product ions at m/z 1080 and 966
correspond to fengycin A and are generated by the neutral losses
of fatty acid –Glu and fatty acid –Glu–Orn, respectively, from
the N-terminus segment of fengycin A (Wang et al., 2004).
Similarly, product ions at m/z 1108 and 994 also indicate neutral
losses of fatty acid –Glu and fatty acid –Glu–Orn, but they are
28 Da heavier than those ions of fengycin A. The observed mass
difference indicates the substitution of Ala for Val at position 6 in
the lactone ring and therefore homologs at m/z 1491.8 and 1505.8
are fengycin B (Wang et al., 2004).
The ESI-MS/MS spectrum of LC peak 2 (m/z 1477.8)
corresponds to fengycin (Figure 1D) and displays two product
ions at m/z 980.4 and 1094.5 (Figure 1E). According to the m/z
values reported by Li et al. (2012) and Pathak et al. (2012), these
product ions correspond to fengycins C, D (or B2) and/or S.
Based on the results obtained, Table 1 summarizes the
correct assignment of fengycins produced by B. amyloliquefaciens
MEP218 in MMOLP medium, detected in the HPLC fraction that
eluted at 27.4 min.
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FIGURE 1 | LC-ESI-MS/MS analysis of fengycins from Bacillus amyloliquefaciens MEP218. Elution profile of fengycins (A), obtained from a HPLC-purified peak after
separation of CLP from B. amyloliquefaciens MEP218, using nanoHPLC technology (Thermo Scientific, EASY-nLC 1000) equipped with a reverse-phase C18
column (Easy-Spray ColumnPepMap RSLC, P/N ES803, 2 µm particle size, 75 µm × 500 mm, Thermo Scientific). ESI-MS/MS spectra of protonated fengycin ions
m/z 1463.8 (B) obtained from peak 1, the spectrum of precursor ion of m/z 1463.8 (C); m/z 1477.8 (D) obtained from peak 2, the spectrum of precursor ion of m/z
1477.8 (E); and ions m/z 1477.8, 1491.8, and 1505.8 (F) obtained from peak 3, the spectrum of precursor ion of m/z 1477.8 (G), 1491.8 (H), and 1505.8 (I) were
acquired in a mass spectrometer (Thermo Scientific, Q-Exactive) with a high collision dissociation (HCD) cell and an Orbitrap analyzer.
TABLE 1 | LC/ESI-MS/MS assignment of protonated fengycins homologs contained in the 27.4 min fraction from Bacillus amyloliquefaciens MEP218 strain.
Retention time Mass peak (m/z) Typical product ions Amino acid at position 6 Amino acid at position 10 Assignment
91.75 1463.8 1066.5 952.4 Ala Val C-16 fengycin A2
1080.5 966.4 Ala Ile C-17 fengycin A
92.43 1477.8 1094.5 980.4 Ala/Val/Ile/Leu Ile/Val C-16 fengycin C, B2, S
94.00 1477.8 1080.5 966.4 Ala Ile C-17 fengycin A
94.13 1491.8 1108.5 994.4 Val Ile C-16 fengycin B
94.56 1505.8 1108.5 994.4 Val Ile C-17 fengycin B
Antibacterial Activity of C16-C17
Fengycins From B. amyloliquefaciens
MEP218 on Xanthomonas axonopodis pv.
vesicatoria and Pseudomonas
aeruginosa PA01
Considering the fact that fengycins produced by MEP218
displayed a strong antibacterial activity against Xav, we assessed
whether this CLP could also be effective against PA01,
a typical human pathogen model. Thus, the antibacterial
activity against Xav and PA01 of C16-C17 fengycins, hereafter
fengycins, was evaluated by determining the MIC and the
bacterial growth inhibition employing the disk diffusion method.
Fengycins exhibited antibacterial activity against Xav and PA01
(Figure 2). The most susceptible bacterial strain to these
fengycins was Xav, showing strong inhibition halos at the
lowest concentration of fengycins assayed (6.25 µg mL−1)
(Figure 2A). PA01 was also inhibited by fengycins although
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FIGURE 2 | Antibacterial activity of fengycins from B. amyloliquefaciens
MEP218 against Xanthomonas axonopodis pv. vesicatoria (A) and
Pseudomonas aeruginosa PA01 (B). Paper disks were imbibed with 10 µL of
fengycins (at 6.25, 12.5 and 25 µg mL−1 for Xav, and 25, 50, 100, and
200 µg mL−1 for PA01) from MEP218, and 10 µL of methanol (MeOH) as a
control.
at higher concentrations (200 µg mL−1) (Figure 2B). The
MIC values were similarly different, with that for Xav
(MIC = 25 µg mL−1) being eight times lower than for
PA01 (MIC = 200 µg mL−1) (data not shown). Disks in-
bedded in methanol (used for making fengycin suspensions),
had no inhibitory effects on Xav or PA01. These results
demonstrated the antibacterial activity of fengycins against
two different bacteria: Xav, a plant pathogen, and PA01, an
opportunistic human pathogen.
Determination of Toxicity of Fengycins
on Human Cells
In order to test the toxicity of fengycins on mammal
cells, the viability of human normal lung fibroblasts
(cell line MRC-5) was determined after treatment with
fengycins at 100 and 200 µg mL−1 by using the 1-(4,5-
dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT) assay.
The viability of fibroblasts treated with fengycins did not
show any significant change (p ≤ 0.05) compared with the
control treatment (phosphate buffered saline), suggesting
that fengycins are not cytotoxic at the concentrations
tested (Figure 3).
Changes in Xav Cell Topography After
Treatment With Fengycins Observed by
AFM
To study possible effects of fengycins on Xav cells at micro-
or nano-scale, bacteria were treated with fengycins or water
(control), and the bacterial cell topography was analyzed by
using AFM. AFM is an extremely useful tool for analyzing the
three-dimensional topography of biological samples, including
bacteria. The technique allows the characterization of the
bacterial cell surface producing high resolution topographical
imaging with minimal sample disruption (Müller and Dufrêne,
2011). Cell suspensions of Xav were treated with 12.5, 25, 50,
or 75 µg mL−1 of fengycins for 90 min. Control experiments
were performed by exposing Xav to water. Representative AFM
images from both control and fengycins treated Xav cells are
FIGURE 3 | Effect of fengycins on cell viability of MRC-5 human normal lung
fibroblasts. The cells were treated with 0, 100, and 200 µg mL−1 of fengycins
(control, F100 and F200, respectively) for 24 h and then the cell viability was
evaluated by MTT assay. The cell viability for the control (without fengycins),
was considered as 100%. Values are the mean ± SD of three independent
experiments with three biological replicates per treatment. Different letters
indicate a statistically significant difference (p ≤ 0.05).
shown in Figure 4. Control Xav cells presented a typical rod shape
with a uniform surface topography (Figures 4A,B). In addition,
a high-resolution image shows a relatively uniform and smooth
cell surface (Figure 4C).
In comparison, clear disturbances in the cell morphology
are observed in cells exposed to 12.5 µg mL−1 of fengycins
(Figure 4D). At higher fengycins concentrations (25 and
50 µg mL−1), the perturbations observed on the cell surface are
more evident. In some cases, only the cell boundaries with some
protruding granules are observed, which gives to the cells an
empty and irregular appearance. Probably, this could represent
the topography of cellular debris that remains after the action of
fengycins (Figure 4E). In other cases, the collapse of the whole
cell was evident (Figure 4F).
Total cell damage is observed at the highest concentration
of fengycins assayed (75 µg mL−1) (Figures 4G,H). High-
resolution images of the cell surface show severe damage
triggered by fengycins exposure (Figure 4I) in comparison with
those of the control cells (Figure 4C). Thus, the topographical
changes observed in the bacterial cells become more pronounced
as the concentration of fengycins used in the treatment increases.
Moreover, a clean substrate surface is observed as background
around the untreated cells (Figures 4A–C). In contrast, small
granules or aggregates are observed on the polymeric support
close to the fengycins-treated cells (Figures 4D–I). This behavior
is concomitant with the damage of cell integrity, suggesting that
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FIGURE 4 | Atomic force microscopy (AFM) images of Xanthomonas axonopodis pv. vesicatoria (Xav) cells after fengycins exposure. Topography of untreated cells
(A,B). Cells topography following fengycins treatments with 12.5 (D), 25 (E), 50 (F), and 75 (G,H) µg mL−1 for 90 min. The star symbols (∗) reveal zoom area of the
figures (B,C∗1) and (H,I∗2).
the aggregates could correspond to intracellular content and/or
cellular debris.
Decreasing of Xav Cell Height by
Fengycins Exposure
Changes in the dimensions of the bacteria were quantified by
measuring, from the AFM topography images (Figures 5D–F),
the cellular height of 70 bacteria per treatment. The analysis
of height distribution in the histogram shows that the most
common frequency of observation for the untreated cells
is found between 120 and 160 nm (Figure 5A). However,
when treatments with fengycins were applied, the frequencies
decreased to 120 nm (Figures 5B,C). In fact, compared with
average height of the control cells (137 nm), a significant
decrease (p ≤ 0.05) is observed after treatments with both 50
and 75 µg mL−1 of fengycins (102 and 93 nm, respectively).
No significant changes were observed in the height distribution
measured between the two concentrations of fengycins assayed.
Therefore, the height reduction observed in cells after the
treatment with fengycins suggests shrinkage in the volume
of Xav cells, probably due to loss of intracellular materials
by cells collapse.
Potassium efflux measurement was performed to determine if
the height decrease of Xav cells treated with fengycins correlated
with damage in the cell envelope and the release of intracellular
content. The treatment of Xav cells with fengycins at two
concentrations: the MIC value (25 µg mL−1) and another
three times higher to ensure the total cell lysis (75 µg mL−1),
caused a significant efflux of potassium ions from Xav cells
(1.58 and 1.63 ppm respectively) compared with the negative
control (0.16 ppm) where water replaced the fengycins (Figure 6).
The positive control, consisting of Xav cells boiled at 100◦C
for 10 min (total lysis), released all the intracellular potassium
content (2.80 ppm).
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FIGURE 5 | Height distribution of Xanthomonas axonopodis pv. vesicatoria (Xav) cells measured by AFM. Fengycins treatment with 50 (B) or 75 µg mL−1 (C)
resulted in a significant decrease (p ≤ 0.05) in the height (across the whole cell) of 70 individual Xav cells in comparison with the untreated cells (A). 3D AFM images
showing changes in cell surface topography quantified using a cell height transect line across similar regions of the Xav cells and a change in cell topography and
surface convolution in x, y, and z directions (D–F).
Fengycins Exposure Also Affects the Cell
Height and Topography of the
Opportunistic Pathogen Pseudomonas
aeruginosa PA01
PA01 cells treated with 200 µg mL−1 of fengycins during 6 h
exhibited reproducible alterations in the cellular topography
compared with the control cells (Figure 7). The same alterations
reported above for the Xav cells were also observed, to a lesser
extent, in PA01 cells; even when the highest concentration of
fengycins was applied. In general, following fengycins treatments,
PA01 cell surface appeared to lose uniformity exhibiting an altered
topography (Figures 7D,E). In contrast, the topography of the
untreated PA01 cells appeared far more uniform (Figures 7A,B).
Histograms (Figures 7C,F) of the average height of the PA01
cells exposed to fengycins (200 µg mL−1) showed a significant
height reduction (72 nm) compared with that of the control
cells (136 nm). The high frequencies of height changed from
120 to 160 nm in the untreated PA01 cells to 40–100 nm in the
cells exposed to fengycins (Figures 7C,F). The above-mentioned
changes suggest that the same cell-perturbing effect observed
for Xav occurred.
DISCUSSION
Morpho-structural alterations of the cell surface and membrane
perturbations of several fungal pathogens have been attributed to
the effect of CLP (Horn et al., 2013; Wise et al., 2014; Sur et al.,
2018; Mantil et al., 2019). Although antifungal activity of CLP has
been widely reported (Cawoy et al., 2015), there is less evidence
about the effect of these antimicrobials on bacteria. Some
authors have attributed to surfactins a moderate antibacterial
activity against some pathogenic bacteria, including S. aureus,
B. subtilis, S. typhimurium, P. aeruginosa, C. variabilis, and
Acinetobacter (Zhao et al., 2018). Iturins have also been indicated
as antibacterial compounds. For example, it was reported that
B. subtilis SSE4 secreted iturin3 and a new class of CLP from
the iturin family, subtulene A. Both CLP showed antibacterial
activity against Stenotrophomonas maltophilia, Acinetobactercal
coaceticus, E. coli, S. typhimurium, Enterobacter cloacae, and
X. campestris (Thasana et al., 2010).
Although fengycins were best described as antifungal
compounds active against plant and human pathogenic fungi we
previously reported a strong antibacterial activity of fengycins
from MEP218 against Xav. In addition, we suggested that
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FIGURE 6 | Potassium efflux of Xanthomonas axonopodis pv. vesicatoria cells
treated with 25 and 75 µg mL−1 of fengycins for 90 min. Positive control
consisted of cell suspensions boiled for 10 min to release intracellular K+ ions.
The graph shows the means ± SE of three independent experiments with
three replicates per experiment. Different letters indicate a statistically
significant difference (p ≤ 0.05).
fengycins could impair the biofilm formation and even disrupt
those preformed Xav biofilms (Medeot et al., 2017).
This work addresses the study of the effect of fengycins
produced by B. amyloliquefaciens MEP218 on Xav and PA01,
a plant pathogen and an opportunistic human pathogen,
respectively. A more detailed mass spectrometry analysis revealed
that the fraction containing fengycins, previously characterized
as fengycins A and B, was indeed a mixture of C16-C17 fengycins
isoforms. The antibacterial activity of fengycins on Xav and PA01
was evidenced initially by the presence of inhibition haloes on
Petri dishes assays.
The AFM is a powerful tool for depicting the three-
dimensional topography of biological samples, including
bacteria. The technique allows the characterization of the
bacterial cell surface producing high resolution topographical
imaging with minimal sample disruption (Müller and Dufrêne,
2011). In this way, AFM experiments performed in this work
allowed to obtain topographical and morphological information
of changes in the bacterial cell after exposure to fengycins.
Untreated Xav cells presented a typical rod shape with a uniform
surface topography, which are in agreement with the previously
described topography for Xav (Fernandez et al., 2017). At high
resolution, alterations on the bacterial surface were observed
in Xav and PA01 cells exposed to fengycins. The strength of
AFM to visualize alterations at the cell surface level allowed the
exploration of the mode of action of several antimicrobial agents
(Braga and Ricci, 2011; Dufrêne, 2014; Longo and Kasas, 2014;
Fernandez et al., 2017). A decrease in cell height, possibly due to
the leakage of intracellular content, was observed. Measurements
of potassium efflux confirmed leakage of the intracellular
content in Xav cells exposed to fengycins. These data suggest
that topographical changes in the cell surface occurred as
consequence of the fengycin treatment.
It is known that the lipid composition of the biological
membranes and the formation of lipid domains are behind
their specific structural properties and functionalities. Bacteria
vary widely in the lipid composition of their membranes and
would, therefore, be expected to exhibit different sensitivities to
antimicrobial compounds that act at the cell surface. For example,
works from Epand demonstrated a strong correlation between
the lipid composition of bacteria and the ability of antimicrobial
FIGURE 7 | Atomic force microscopy images of P. aeruginosa PA01 cells after fengycins exposure. Topography of untreated cells (A). Cells topography after the
treatment with 200 µg mL−1 of fengycins for 6 h (D). The star symbols (∗) reveal zoom area of the figures (A,B∗1) and (D,E∗2). Fengycins treatment resulted in a
significant decrease (p ≤ 0.05) in height (across the whole cell) of 70 individual PA01 cells in comparison with the control (C,F).
Frontiers in Microbiology | www.frontiersin.org 9 January 2020 | Volume 10 | Article 3107
fmicb-10-03107 January 9, 2020 Time: 18:31 # 10
Medeot et al. Antibacterial Activity of Fengycins From Bacillus
agents to induce their toxic effects (Epand and Epand, 2009;
Epand et al., 2016). To our knowledge, there are only a few studies
addressing the mechanisms of action of the fengycins, and most
of them were carried out in very simple membrane models that do
not represent the complexity of the biological membranes (Deleu
et al., 2005, 2008; Eeman et al., 2005; Fiedler and Heerklotz,
2015). Although the mode of action of the fengycins is not yet
understood, our results provide new evidence supporting the
role of fengycins as a macromolecule that causes damage to the
cellular envelope of sensitive cells.
Molecular dynamics simulations have been used to explain
the functional selectivity of fengycins on artificial membranes
composed of PE:PG or PC as models for bacterial and eukaryotic
membranes, respectively (Sur et al., 2018). Fengycin interacts
with lipid monolayers at the air-aqueous interface. It is thought
that the ability of fengycins to damage cell membranes, and
thereof to cause cell disruption, depends on the aggregation
of fengycins and this phenomenon depends on the membrane
lipid composition of the target cell. For instance, Sur et al.
(2018) demonstrated clear differences in the number, size and
lifetime of the fengycin aggregates between both models of
membranes, eukaryotic and bacterial. Similarly, Deleu et al.
(2008) demonstrated that fengycin insertion into biological
membranes produces perturbation and partial dissolution of the
dipalmitoylphosphatidylcholine (DPPC) condensed domains,
which are partially mixed with fengycin. Those results suggested
that fengycin and DPPC interact in the membrane. In agreement
with the above mentioned, membranes of both Xav and PA01
strains used in this study contain PC, a phospholipid relatively
unusual in bacteria (Geiger et al., 2003; Aktas and Narberhaus,
2015). Based on those studies and depending on the fengycin
concentration, two mechanisms of action were proposed: under
low fengycin concentrations, fengycin aggregates causing the
formation of pores and the subsequent changes in membrane
permeability, whereas, at high concentration, fengycin solubilize
the membrane similarly as a detergent (Deleu et al., 2005,
2008). Furthermore, it was reported that in DPPC bilayers,
fengycin domains are segregated laterally close to the lipid/water
interface causing extensive dehydration of the polar region
of the membrane. This behavior suggested that fengycin-rich
domains may constitute the sites of membrane permeabilization
(González-Jaramillo et al., 2017). Other authors highlighted
that the insertion of fengycin into the fungal membrane
may be associated with low content in anionic phospholipids,
thus reducing the electrostatic repulsion with the negatively
charged fengycin (Wise et al., 2014). The differences in
sensitivity to fengycins observed in Xav and PA01 could be
attributed to the intrinsic membrane lipid composition of these
bacterial species.
Moreover, it is well-known that fengycins are fungicides
but they have little or no effect on mammal cells, both
eukaryotic membranes. It has been speculated that this
differential selectivity of fengycins may be attributed to the
presence of different sterols, ergosterol in the fungal membranes
and cholesterol in the mammalian membranes. Apparently,
cholesterol may have a protective effect on mammalian
membranes (Fiedler and Heerklotz, 2015).
In summary, the AFM was a useful tool to analyze the
alterations in the topography of Xav and PA01 cells in response
to the exposure to C16–C17 fengycin isoforms produced by B.
amyloliquefaciens MEP218. Interestingly, in this work, we also
showed that the cell viability of human normal lung fibroblasts
was not affected after treatment with the highest concentration
of fengycins tested. More intriguing, there are reports indicating
that fengycins exposure, until 200 µg mL−1, may play certain
inhibitory roles on the development and progression of cancer
colon ephitelial cells whereas no cytotoxic effects have been
observed in normal colon ephitelial cells (Yin et al., 2013; Cheng
et al., 2016). Despite these reports, there are no studies addressing
this selective targeting of the fengycins for cancer cells. The
results presented in this work give visual examples and real
quantitative data on the poor characterized role of fengycins
as antibacterial compounds. Fengycin exposure causes dramatic
and unprecedented alterations in the topography of Xav and
PA01 cells, which result in the cell death by leaking of the
intracellular content.
Considering that the application of antimicrobial peptides in
clinical has provided to be highly relevant for the treatment of
diseases caused by bacteria the data present here could be a start
point for the design of novel antimicrobial agents.
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